- Home/In The News/Blog/2013
24
December2013
category:
503b CompoundingSettlement reached over deadly U.S. meningitis outbreak
Owners and insurers of a now-bankrupt Massachusetts pharmacy linked to a deadly meningitis outbreak have agreed to pay more than $100 million to compensate victims, families of victims and creditors. The preliminary settlement announced on Monday, which requires court approval, would resolve many claims arising from tainted steroid injections linked to New England Compounding Pharmacy […]
read more24
December2013
category:
503b Compounding$100 million agreement close in tainted drug case
The owners and insurers of the bankrupt Framingham pharmacy blamed for an outbreak of fungal meningitis that killed dozens of people last year have tentatively agreed to contribute more than $100 million to compensate victims and creditors of the firm. The proposed settlement, which needs to be finalized and approved by the US Bankruptcy Court, […]
read more24
December2013
category:
503b CompoundingMassachusetts Pharmacy in Settlement Over Tainted Injections
The Massachusetts pharmacy whose tainted steroid injections were blamed for a deadly outbreak of fungal meningitis has agreed to pay more than $100 million to victims and their families, according to lawyers involved in a tentative settlement. The tentative deal is part of an effort to compensate victims and their families for injuries they suffered […]
read more